Dexcom’s cover photo
Dexcom

Dexcom

Medical Equipment Manufacturing

San Diego, California 241,172 followers

About us

Empowering People to Take Control of Health Dexcom Corporation (NASDAQ DXCM) has been a pioneer in glucose sensing for more than 25 years. Since 1999, we have developed innovative technologies that transformed how people manage diabetes. Our products are part of people’s daily lives, empowering them to live confidently and feel more in control, free to pursue their dreams. Headquartered in San Diego, California, with operations around the world, Dexcom leads by listening to the needs of users, caregivers, and providers, to simplify and improve glucose management.

Website
https://careers.dexcom.com/careers/index
Industry
Medical Equipment Manufacturing
Company size
10,001+ employees
Headquarters
San Diego, California
Type
Public Company
Specialties
Continuous Glucose Monitoring, Medical Devices, Diabetes, Decision Support, Data, Mobile Software, Sensors, Biosensors, Glucose Biosensors, and Wellness

Locations

Employees at Dexcom

Updates

  • View organization page for Dexcom

    241,172 followers

    Dexcom has teamed up with DAV (Disabled American Veterans) to launch a new diabetes resource page created just for veterans. With diabetes impacting nearly 1 in 4 veterans, this page is designed to help veterans feel empowered and supported in managing their health. Thank you to the team at DAV for being great partners. We are proud of the work we’re doing together to support those who have served.

    DAV is excited to announce the launch of our diabetes resource page for veterans! The goal of this page, created in partnership with Dexcom, is to empower veterans with diabetes and ensure they have the necessary knowledge and tools to lead healthier lives. Dexcom is a well-trusted name in the industry and we are grateful for their partnership and support in creating this critical resource. Check out the resource page below and share to help spread the word.

  • View organization page for Dexcom

    241,172 followers

    Following one of the world’s leading diabetes conferences and nearing his first 90 days as President and CEO, Jake Leach is sharing a video update on Dexcom’s future. Jake talks through the priorities guiding Dexcom’s next chapter, anchored by what has always mattered most: the people we serve. That commitment has shaped Dexcom from the start and continues to drive us forward. Watch the video.

  • View organization page for Dexcom

    241,172 followers

    The future of women in STEM is already taking shape. At Cal Poly’s SWE Evening with Industry, Anna Chan, Senior Director of Process Development Engineering, and Amanda Clement, Senior Automation Engineer, had the privilege of meeting Engineering students who are passionate, motivated, and eager to create the next generation of innovations. Their ambition and talent were truly inspiring, serving as a testament to the significance of supporting early-career engineers. Browse the carousel to read more from Anna and Amanda. Explore summer internship and early careers opportunities via the link in the comments below. 👇

  • View organization page for Dexcom

    241,172 followers

    We’re excited to be in Barcelona for the 19th annual Advanced Technologies & Treatments for Diabetes (ATTD) showcasing how Dexcom’s latest findings and innovations are transforming care for people with all types of diabetes. Highlights from the week include: • New registry study data shows that long-term use of Dexcom G7 supports weight management and lowers A1C for people with Type 2 diabetes who aren’t on insulin therapy, reinforcing the need to broaden CGM access beyond insulin-treated populations. • New evidence shows how Dexcom CGM can help improve long-term health and reduce hospitalizations across diabetes types. • Symposium on Thursday, March 12, led by Girish Naganathan, will highlight upcoming product features across Dexcom’s global portfolio. Every year, ATTD continues to push diabetes care forward. We’re proud of the role we play in shaping the future of glucose biosensing and advancing metabolic health worldwide. For more information about Dexcom's presence at ATTD, read the news release here https://lnkd.in/1wf642v4. And to register to virtually attend the conference, visit https://lnkd.in/64h0yrrm. #ATTD2026 #Dexcom #GlucoseBiosensing #DiabetesCare #CGM

    • No alternative text description for this image
  • View organization page for Dexcom

    241,172 followers

    On International Women’s Day, we’re proud to celebrate the women who make a profound impact across the globe and within Dexcom. Across our organization, women play a critical role in driving innovation and delivering life-changing CGM technology to people living with diabetes around the world. At Dexcom, we’re committed to creating an environment where all women can thrive, grow, and lead. Our WIN+ (Women’s Initiative Network) Employee Resource Group continues to champion this work by elevating women’s voices and fostering meaningful allyship across our global workforce. Today and every day, we celebrate the women driving impact at Dexcom and within communities worldwide.

    • No alternative text description for this image
  • View organization page for Dexcom

    241,172 followers

    We’re proud to share that Dexcom President & CEO, Jake Leach, has been named Chair of the AdvaMed Diabetes Sector. AdvaMed brings together the world’s leading innovators in diabetes technology, and as Chair, Jake will help champion policies that expand access to diabetes technologies, improve patient outcomes, and support equitable care for all patients. Congratulations, Jake!

    View organization page for AdvaMed

    24,402 followers

    AdvaMed is pleased to announce that Jake Leach, President and CEO of Dexcom, has been named Chair of the AdvaMed Diabetes Sector, succeeding Chris Scoggins, Executive Vice President of Diabetes Care at Abbott. The Diabetes Sector represents the world’s leading companies producing technology across the spectrum of diabetes care. “Jake brings decades of experience advancing patient-centered diabetes care and driving innovation across the medtech industry,” said Scott Whitaker, AdvaMed president and CEO. “The AdvaMed Diabetes Sector plays a critical role in advocating for policies that expand access to diabetes technologies, improve patient outcomes, and support equitable care for all patients. Thank you, Jake, for your willingness to lead in this important role.” Whitaker also expressed gratitude to Scoggins for his leadership. “Chris led the AdvaMed Diabetes Sector with a clear focus on the patients and families who depend on these technologies every day,” Whitaker said. “At a time of rapid innovation and important policy conversations around access and affordability, his leadership helped strengthen our voice and advance solutions that empower people with diabetes to live healthier, fuller lives.” Eric Benjamin, Executive Vice President and Chief Operating Officer at Insulet Corporation, will serve as the sector’s vice chair. Read the full announcement here: https://lnkd.in/eRpHSBHc

    • No alternative text description for this image
  • View organization page for Dexcom

    241,172 followers

    At Dexcom, we’re committed to advancing health equity through employee-led initiatives and community partnerships that help us better understand and support the experiences of Black patients, caregivers, employees, and communities. This Black History Month, we celebrate the leadership and contributions of Black individuals and recommit to driving meaningful progress in equity and inclusion. Our Dexcom African Ancestry Network (DAAN) continues to lead this work by fostering connection, learning, and amplifying Black voices across the company. This year, we were honored to host Dr. Justene Hill Edwards for our global Black History Month event. Her remarks examined the history and legacy of Freedman’s Bank, underscoring its significance in shaping conversations around economic equity and the enduring impacts of historical financial systems. The session fostered thoughtful dialogue and meaningful shared learning across our global community.

    • No alternative text description for this image
  • View organization page for Dexcom

    241,172 followers

    Continuing to transform how people manage their glucose, Dexcom is proud to announce new features coming to Stelo, the first over-the-counter glucose biosensor cleared* by the FDA in the United States. 𝗔𝗱𝘃𝗮𝗻𝗰𝗲𝗱 𝗔𝗜-𝗲𝗻𝗮𝗯𝗹𝗲𝗱 𝗦𝗺𝗮𝗿𝘁 𝗙𝗼𝗼𝗱 𝗟𝗼𝗴𝗴𝗶𝗻𝗴: • Expansion of previously launched Smart Food Logging feature • Integrates a comprehensive nutrition database that provides a breakdown of calories, carbohydrates, protein, fat, dietary fibers, and more • Includes over 1M food options • Multiple ways to log a meal, including text search, barcode scanning or taking a photo of the meal 𝗥𝗲𝗱𝗲𝘀𝗶𝗴𝗻𝗲𝗱 𝗗𝗮𝗶𝗹𝘆 𝗜𝗻𝘀𝗶𝗴𝗵𝘁𝘀: • New interface with a sophisticated, card-based system • Users will receive up to three personalized recommendations based on their previous day's glucose, activity, nutrition, and sleep data • Personalized coaching that adapts to individual patterns and progress    These features, launching nationwide in the coming weeks, will empower users with even more information to better understand and manage their metabolic health. Read more here: https://lnkd.in/gkGyFBUK *Dexcom, Stelo User Guide, 2024.

    • No alternative text description for this image
  • View organization page for Dexcom

    241,172 followers

    Honored to see Dexcom recognized on Corporate Knights 2026 Global 100 list of the world’s most sustainable companies, debuting at #16. This recognition reflects our belief that empowering people to take control of their health through glucose biosensing technology goes hand in hand with building a more sustainable future. Thank you to our global teams for continuing to move us forward.

    • No alternative text description for this image

Affiliated pages

Similar pages

Browse jobs

Funding

Dexcom 8 total rounds

Last Round

Post IPO debt

US$ 1.0B

See more info on crunchbase